- Home
- SERA
as 12-20-2024 3:42pm EST
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 208.7M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 87.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.99 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.90 - $12.36 | Next Earning Date: | 11-06-2024 |
| Revenue: | $94,000 | Revenue Growth: | -71.52% |
| Revenue Growth (this year): | -65% | Revenue Growth (next year): | 4471.43% |
Stock Insider Trading Activity of Sera Prognostics Inc. (SERA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Lindgardt Zhenya | SERA | Chief Executive Officer | Dec 10 '24 | Sell | $7.41 | 26,224 | $194,319.84 | 793,534 | |
| Aerts Austin | SERA | Chief Financial Officer | Dec 10 '24 | Sell | $7.41 | 5,730 | $42,459.30 | 285,756 | |
| Boniface John J. | SERA | Chief Scientific Officer | Nov 11 '24 | Sell | $7.32 | 4,727 | $34,601.64 | 125,120 | |
| Lindgardt Zhenya | SERA | Chief Executive Officer | Nov 11 '24 | Sell | $7.32 | 12,075 | $88,389.00 | 793,534 | |
| Kearney Paul | SERA | Chief Data Officer | Nov 11 '24 | Sell | $7.32 | 4,078 | $29,850.96 | 176,889 | |
| Jackson Benjamin | SERA | General Counsel | Nov 11 '24 | Sell | $7.32 | 4,727 | $34,601.64 | 135,528 | |
| Aerts Austin | SERA | Chief Financial Officer | Nov 11 '24 | Sell | $7.32 | 7,179 | $52,550.28 | 285,756 | |
| Harrison Robert Gardner | SERA | Chief Information Officer | Nov 11 '24 | Sell | $7.32 | 4,727 | $34,601.64 | 131,046 | |
| Mirza Mansoor Raza | SERA | Director | Nov 11 '24 | Sell | $7.32 | 95 | $695.40 | 6,729 | |
| Mirza Mansoor Raza | SERA | Director | Oct 7 '24 | Sell | $7.15 | 96 | $686.40 | 6,729 |
Latest Sera Prognostics Inc. News
SERA Breaking Stock News: Dive into SERA Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
With 40% stake, Sera Prognostics, Inc. (NASDAQ:SERA) seems to have captured institutional investors' interest
PR Newswire
17 days ago
Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting
PR Newswire
20 days ago
Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference
Fortune
a month ago
5 investing trends for 2025—and 15 stocks to help you bet on them
PR Newswire
a month ago
Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Simply Wall St.
a month ago
Sera Prognostics (NASDAQ:SERA) Is In A Strong Position To Grow Its Business
Simply Wall St.
a month ago
Sera Prognostics Third Quarter 2024 Earnings: Misses Expectations
Zacks
a month ago
Sera Prognostics, Inc. (SERA) Reports Q3 Loss, Lags Revenue Estimates
Compare SERA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SERA Sera Prognostics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.